v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash flows provided by operating activities:              
Net income $ 72,582 $ 104,751 $ 203,516 $ 160,812 $ 177,333 $ 364,328  
Adjustments to reconcile net income to net cash provided by operating activities:              
Depreciation and amortization expense         181,098 193,676  
Impairment of operating right-of-use assets and related property, plant and equipment         0 5,573  
Reduction in carrying value of operating right-of-use assets         17,888 18,977  
Loss on disposal of subsidiary undertaking 32,947   0   32,947 0  
Amortization of financing costs and debt discount         3,048 2,971  
Stock compensation expense         46,030 27,610  
Deferred tax benefit         (26,142) (46,095)  
Unrealized foreign exchange movements         (22,905) 34,777  
Other non-cash items         5,048 15,266  
Changes in operating assets and liabilities:              
Accounts receivable         (46,728) 15,149  
Unbilled revenue         34,981 (138,521)  
Unearned revenue         107,463 25,761  
Other net assets         (61,785) (105,031)  
Net cash provided by operating activities         448,276 414,441  
Cash flows used in investing activities:              
Purchase of property, plant and equipment         (73,193) (61,185)  
Purchase of subsidiary undertakings (net of cash acquired)         0 (2,537)  
Cash outflow on disposal of subsidiary undertaking (including cash sold)         (55,513) 0  
Proceeds from investments in equity         4,741 561  
Purchase of investments in equity         (23,809) (12,330)  
Net cash used in investing activities         (147,774) (75,491)  
Cash flows used in financing activities:              
Debt issue costs         (2,294) 0  
Drawdown of credit lines and loan facilities         0 50,000  
Repayment of credit lines and loan facilities         (14,881) (64,881)  
Proceeds from exercise of equity compensation         2,710 6,498  
Share issue costs         (9) (9)  
Repurchase of ordinary shares         0 (500,000)  
Share repurchase costs         0 (300)  
Net cash used in financing activities         (14,474) (508,692)  
Effect of exchange rate movements on cash         (4,938) 21,353  
Net increase / (decrease) in cash and cash equivalents         281,090 (148,389)  
Cash and cash equivalents at beginning of period   $ 647,295   $ 538,785 647,295 538,785 $ 538,785
Cash and cash equivalents at end of period $ 928,385   $ 390,396   $ 928,385 $ 390,396 $ 647,295